SOA Wealth Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07K Sell
179
-3
-2% -$23 ﹤0.01% 746
2025
Q4
$1.31K Hold
182
﹤0.01% 741
2025
Q3
$1.94K Sell
182
-3
-2% -$29 ﹤0.01% 728
2025
Q2
$1.79K Sell
185
-187
-50% -$1.93K ﹤0.01% 726
2025
Q1
$5.54K Sell
372
-29
-7% -$446 ﹤0.01% 625
2024
Q4
$5.99K Sell
401
-8
-2% -$130 ﹤0.01% 601
2024
Q3
$7.82K Buy
409
+4
+1% +$83 ﹤0.01% 564
2024
Q2
$8.38K Sell
405
-161
-28% -$3.2K ﹤0.01% 556
2024
Q1
$10.7K Sell
566
-39
-6% -$669 ﹤0.01% 531
2023
Q4
$8.72K Sell
605
-103
-15% -$1.4K ﹤0.01% 544
2023
Q3
$12.3K Sell
708
-10
-1% -$209 ﹤0.01% 496
2023
Q2
$14.9K Sell
718
-35
-5% -$761 ﹤0.01% 475
2023
Q1
$17.7K Buy
753
+6
+0.8% +$161 ﹤0.01% 446
2022
Q4
$20.9K Sell
747
-16
-2% -$409 0.01% 399
2022
Q3
$17K Sell
763
-38
-5% -$1.15K 0.01% 417
2022
Q2
$27K Sell
801
-517
-39% -$18.1K 0.01% 342
2022
Q1
$46K Buy
1,318
+22
+2% +$752 0.01% 323
2021
Q4
$39K Sell
1,296
-27
-2% -$879 0.01% 331
2021
Q3
$43K Buy
+1,323
New +$42.3K 0.01% 325

Other funds holding OGN

SOA Wealth Advisors's OGN Position: Q1 2026 in Review

SOA Wealth Advisors reduced its Organon & Co (OGN) stake by 1.6% in Q1 2026, selling an estimated $23 and leaving 179 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #746.

SOA Wealth Advisors first reported a position in OGN in Q3 2021 and has held it in 19 quarters since. The position peaked at $46K in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • SOA Wealth Advisors held 179 shares of Organon & Co worth $1.07K as of Q1 2026.
  • SOA Wealth Advisors sold 3 Organon & Co shares in Q1 2026, an estimated $23.
  • Organon & Co made up ﹤0.01% of SOA Wealth Advisors's portfolio in Q1 2026, its #746 holding.
  • SOA Wealth Advisors first reported a position in Organon & Co in Q3 2021 and has held it in 19 quarters since.
  • SOA Wealth Advisors's Organon & Co position peaked at $46K in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on SOA Wealth Advisors's 13F filing for Q1 2026, filed 20 May 2026.